UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

A new wave of biomimetic ingredients is reshaping skincare, tapping into the skin’s own repair and defence systems to deliver deeper, longer-lasting results.

A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

Scientists have demonstrated a dependable method to generate large numbers of helper T cells from stem cells, removing a long-standing obstacle that has limited immune-based cancer treatments. The ...

A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive and currently incurable form of brain ...

Korean kimchi may boost immune function, according to a new study. Researchers found measurable changes in immune cell ...

Scientists at the University of British Columbia have developed a method to reliably grow helper T cells from stem cells in ...

The research, funded in part by the National Institutes of Health and published Jan. 21 in Nature, showed that deoxyhypusine ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.